Nuvation Bio Inc. (NUVB) Misses Q4 EPS by 2c

Nuvation Bio Inc. (NYSE: NUVB) reported Q4 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $41.9 million versus the consensus estimate of $38.55 million.

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Micron Technology (MU) PT Lowered to $1,400 at Wells Fargo
• Guardians of the Wind Animation Highlights China-Greece Cooperation in Clean Energy